Cargando…
Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells
Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinical...
Autores principales: | Bachmeier, Beatrice, Fichtner, Iduna, Killian, Peter H., Kronski, Emanuel, Pfeffer, Ulrich, Efferth, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102747/ https://www.ncbi.nlm.nih.gov/pubmed/21637790 http://dx.doi.org/10.1371/journal.pone.0020550 |
Ejemplares similares
-
A highly invasive subpopulation of MDA-MB-231 breast cancer cells shows accelerated growth, differential chemoresistance, features of apocrine tumors and reduced tumorigenicity in vivo
por: Amaro, Adriana, et al.
Publicado: (2016) -
Density-dependent lineage instability of MDA-MB-435 breast cancer cells
por: NERLICH, ANDREAS G., et al.
Publicado: (2013) -
Effects of FSTL1 on cell proliferation in breast cancer cell line MDA-MB-231 and its brain metastatic variant MDA-MB-231-BR
por: An, Jiaqiang, et al.
Publicado: (2017) -
Action and Signaling of Lysophosphatidylethanolamine in MDA-MB-231 Breast Cancer Cells
por: Park, Soo-Jin, et al.
Publicado: (2014) -
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
por: Xie, Jing, et al.
Publicado: (2016)